1. Home
  2. WEYS vs AQST Comparison

WEYS vs AQST Comparison

Compare WEYS & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

SELL

Current Price

$50.03

Market Cap

486.0M

ML Signal

SELL

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

BUY

Current Price

$4.56

Market Cap

529.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
WEYS
AQST
Founded
1906
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
486.0M
529.4M
IPO Year
1995
2007

Fundamental Metrics

Financial Performance
Metric
WEYS
AQST
Price
$50.03
$4.56
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $9.33
AVG Volume (30 Days)
25.1K
★ 2.2M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 2.20%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 2.04
N/A
Revenue
★ $276,169,000.00
$67,430,000.00
Revenue This Year
N/A
$12.09
Revenue Next Year
N/A
$35.73
P/E Ratio
$24.61
★ N/A
Revenue Growth
N/A
★ 0.77
52 Week Low
$27.25
$2.94
52 Week High
$50.48
$7.55

Technical Indicators

Market Signals
Indicator
WEYS
AQST
Relative Strength Index (RSI) 72.90 44.87
Support Level $43.59 $4.51
Resistance Level N/A $4.69
Average True Range (ATR) 1.50 0.21
MACD 0.46 -0.06
Stochastic Oscillator 90.64 17.91

Price Performance

Historical Comparison
WEYS
AQST

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: